Objectives: Tuberculosis is one the most prevalent microbial diseases worldwide and hepatotoxicity is one of the major side effects of first line anti-tubercular drug, Isoniazid. The reported pharmacological activities of Nigella sativa oil include protection from liver damage caused by diseases, chemicals and chemotherapeutic agents. The aim of the present study was to evaluate therapeutic potential of Nigella sativa oil in hepatotoxicity induced by using Isoniazid. Methods: Isoniazid (50 mg/kg) was administered to all the animals for 28 days orally. Silymarin (50 mg/kg) was used as standard drug for this study. From 29 th day onwards isoniazid was stopped and therapeutic agents -normal saline, silymarin, Nigella sativa oil 0.5 ml /kg and 1ml/kg were given orally for the next 15 days in different animal groups respectively. On 44 th day rats were sacrificed, blood samples were collected for biochemical analysis and liver tissue was subjected to histopathological examination. Results: The rats treated with N. sativa oil showed significant reduction in the liver enzymes and total bilirubin levels when compared to negative control group. There was also significant improvement in the histopathological scores in N. sativa oil treated group when compared to the negative control group. Conclusion: This study demonstrates the effectiveness of Nigella sativa oil as a therapeutic agent in hepatotoxicity induced by isoniazid in a dose dependant manner.
INTRODUCTION
Tuberculosis is one the most prevalent microbial diseases worldwide. According to the WHO, India had the highest TB burden worldwide for the year 2014, with approximate 23% out of the global estimate of new incidences.
1 Hepatotoxicity is a well reported and documented adverse effect of the 1 st line antitubercular drugs, which often leads to discontinuation of the drugs and relapse or failure of the therapy. The first line antitubercular drugs, which have the highest reported hepatoxicity, are isoniazid and pyrazinamide and concomitant use of these drugs might lead to fulminant hepatitis with lethal consequences. 2 The drug isoniazid continues to be a leading cause of drug induced hepatic injury in the United States and its hepatotoxicity has often been Submission Date: 12-06-2018; Revision Date: 24-10-2018; Accepted Date: 14-11-2018 significantly under-reported. 3 Elevations in the levels of hepatic transaminases are often encountered with the use of the drug Isoniazid. Severe hepatic injury is seen in approximately 1% of the people taking isoniazid. Liver damage in isoniazid therapy is found out to be age dependent, as it rarely in individuals taking this drug below the age of 20, but the incidence of liver damage increases to 1.2% between the ages of 35 to 49 years and approximately 2.3% in the 50 and above age group. 4 The hepatotoxicity of isoniazid in most cases is dose related, however some instances can be ascribed to drug hypersensitivity. The hepatic damage caused by the drug isoniazid can be related to genetic polymorphism in acetylation of this drug whereas other risk factors include old age, malnutrition, alcoholism, HIV infection and Hepatitis B or C infection. 5 Plant derivatives with purported hepatoprotective activity have been used in folk medicine and traditional systems of medicine around the world for centuries. Nigella sativa L. (Black cumin) is an herbaceous plant, which has used since time immemorial for treatment of various ailments in different systems of traditional medicine. 6 Nigella sativa seed possess various reported pharmacological properties like analgesic, anti-inflammatory, antipyretic, antineoplastic, antioxidant and others. [7] [8] [9] The hepatoprotective activity of Nigella sativa has also been explored. 10, 11 But there are only few reports regarding the protective activity of Nigella sativa seeds against antitubercular drug induced hepatotoxicity. In view of the above, this study was planned to evaluate the therapeutic aspect of Nigella sativa oil in isoniazid induced hepatotoxicity in rats.
MATERIALS AND METHODS

Experimental Animals
Adult wistar albino rats of either sex (150-200g) were obtained from Central Animal House, Jawaharlal Nehru Medical College; Aligarh Muslim University, Aligarh, U.P. They were housed under standard conditions (temperature 27 ± 2°C, Humidity 30-70% and 12 h light/dark cycles). They were fed with standard pellet diet and water ad libitum. The rats were acclimatized to the laboratory condition for 1 week prior to the experiments. The study protocol was approved by the Institutional Animal Ethics Committee (IAEC) on 20.12.2014. All the animal experiments were carried out as per the rules and regulations of IAEC and CPCSEA.
Drugs and chemicals
• Nigella sativa oil (Kalonji oil) was obtained from (Mohammedia products, Aamirnagar, Shah Sahab Mohalla, Karimnagar -505001, Telengana State., India).
• Isoniazid Dispersible Tablets (Macleod's Pharmaceuticals Ltd. Mumbai, Maharashtra India).
• Normal Saline (Swaroop Pharmaceuticals Pvt. Ltd. Aligarh).
• Silymarin suspension (Micro Labs Ltd. Bengaluru, Karnataka, India) was used as the standard drug for the purpose of this study. Diagnostic kits used for the purpose of this study were Bilirubin kit (Accurex Biomedicals pvt. Ltd., Mumbai, India), Aspartate transaminase (AST), Alanine transaminase (ALT) kits -Span Diagnostics Ltd. (Surat, India.) and Alkaline Phosphatase (ALP) kit -Beacon Diagnostics, Gujrat India.
Induction of hepatotoxicity
Hepatotoxicity was induced in the animals by using isoniazid 50mg/kg orally for 28 days.
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Experimental design
Thirty albino rats of either sex, weighing 100-200 g were divided into five groups of 6 animals each. All the drugs were administered orally. Isoniazid dispersible tablets were dissolved in distilled water and administered to all the animals for 28 days orally. From 29 th day onwards isoniazid was stopped and the therapeutic agent's normal saline, silymarin 50mg/kg 13 or Nigella sativa oil 0.5ml/kg and 1ml/kg were given orally for the next 15 days (Table 1) . The animals were sacrificed, blood samples were collected from the heart of animals using open approach on 44 th day and were subjected to biochemical analysis (Serum Billirubin, AST, ALT and ALP), liver removed and physical parameters (weight of the liver per 100 gram of rat's weight and volume of the liver in ml per 100 gram of the rat's weight) were recorded. The liver tissues were then subjected to histo-pathogical analysis.
Biochemical analysis
The blood samples were collected by cardiac puncture (open approach) and centrifuged at 5000 rpm for 10 min, plasma was separated and subjected to biochemical analysis. Total bilirubin was estimated using the method described by Jendrassik L. et al. 1938 14 using reagent supplied by Accurex Biomedicals Pvt Ltd. India. AST and ALT levels were determined by the Reitman and Frankel 15 method using kits acquired from Span Diagnostics Ltd. (Surat, India). Serum ALP levels were estimated by King's method 16 using the ALP determination kit procured from Beacon Diagnostics, Gujrat India.
Histological Examination
The liver samples were preserved in 10% formalin for 48 h, fixed in paraffin. The tissue samples were processed according to standard histological techniques Table1: Grouping of Animals.
Groups
Day1-28 Day 29-43
Group I Normal saline 1ml/kg. Normal saline 1ml/kg. and stained with hematoxylin and eosin. 17 The assessment of damage of liver tissue was done by method described by described by Davidson C.S. 1979. 18 The various parameters used were degeneration, necrosis, fibrosis and regeneration. The percent of hepatoprotection offered by the standard and test drug was calculated using the formula:
Where H = Percentage of hepatoprotection, T = Mean value of group treated with test drugs, C = Mean value of group treated with Isoniazid, V = Mean value for normal control group animals.
Statistical analysis
The data of study are expressed as Mean ± Standard Error of Mean (SEM). The groups were compared by one way analysis of variance (ANOVA) followed by post hoc Tukey's test to analyze the statistical significance. P value of less than 0.05 was considered significant for this study.
RESULTS
Effects of N. sativa oil on the liver function parameters in isoniazid treated rats
The biochemical parameters studied were total bilirubin, AST (aspartate aminotransferase), ALT (alanine aminotransferase) and ALP (alkaline phosphatase). In the negative control (Group II) group the liver function parameters total bilirubin (p<0.001), AST (p<0.001) and ALT (p<0.001) showed significant rise and ALP level was also raised significantly (P<0.01) in comparison to the normal control group (Group I). All the liver function parameters except ALP in the animals of the positive control group (III) showed significant reduction, total bilirubin (p<0.001), AST (p<0.001) and ALT (p<0.001) in comparison to the negative control group (Group II). ALP values in the positive control group (Group III) also showed reduction but were not statistically significant when compared to the negative control group (Group II). In the rats of the N. sativa oil low dose group (Group IV) bilirubin levels showed significant (p<0.001) reduction in comparison to the negative control group (Group II). Serum ALT levels also exhibited significant (p<0.01) reduction, serum AST and ALP levels were reduced but were not statistically significant in comparison to the negative control group (Group II). The animals treated with N. sativa oil high dose (Group V) exhibited significant reduction in the levels of total billirubin (p<0.001), AST (p<0.01) and ALT (p<0.001) when compared to the negative control group (Group II), the ALP levels also showed reduction in comparison to the negative control group (Group II) but it was not statistically significant ( Table 2 ). All data are expressed as Mean± SE. Negative control (Group II) group was compared with Normal control group (Group I) and all other groups (Group III, IV and V) were compared with Negative control group (Group II), * p< 0.05, **p<0.01 and ***p<0.001 were considered significant.
Percentage of Hepatoprotection offered by N. sativa oil low and high dose in isoniazid induced hepatotoxicity
The hepatoprotection offered by the test drugs was estimated by formula described in the section of material and methods. The percentage of hepatoprotection was determined as a function of AST, ALT, ALP and Total bilirubin in all test groups as shown in Table 3 . Percentage of hepatoprotection was highest for the positive control group (Group III) i.e. 81%, 88%, 83% and 54 % for bilirubin AST, ALT and ALP respectively. Among the N. sativa oil test groups hepatoprotection for the low dose group (Group IV) was 65%, 29%, 58% and 29% for bilirubin AST, ALT and ALP respectively and 72%, 66%, 72% and 36% for the high dose group (Group V).
Effects of N. sativa oil on the histopathological examination in isoniazid treated rats
The histopathological parameters studied were degeneration, necrosis, fibrosis and regeneration. The microscopic architecture of the liver appeared to be normal in the normal control group (Group I) with no degeneration, necrosis and fibrosis. In the negative control group (Group II) the liver histopathological score was grossly deranged with significant degeneration (p<0.001), necrosis (p<0.001) and fibrosis (p<0.001) with no regeneration in comparison to normal control group (Group I).In the positive control group (Group III) the liver histopathological scores showed improvement. The degeneration (p<0.001), necrosis (p<0.05) and fibrosis (p<0.05) scores exhibited significant reduction and also there was significant increase in regeneration (p<0.001) in comparison to the negative control group (Group II). In N. sativa oil low dose group (Group IV), there was a decrease in the degeneration, necrosis and fibrosis scores but were not statistically significant and also there was significant regeneration (p<0.01) in comparison to the negative control group (Group II). In N. sativa oil high dose group (Group V) the degeneration (p<0.01), necrosis scores (p<0.05) and fibrosis scores (p<0.05) exhibited significant reduction and also there was significant regeneration (p<0.001) in comparison to the negative control group (Group II) ( Table 4 ). All data are expressed as Mean± SE. Negative control (Group II) group was compared with Normal control group (Group I) and all other groups (Group III, IV and V) were compared with Negative control group (Group II), * p< 0.05, **p<0.01 and ***p<0.001 were considered significant.
DISCUSSION
In day to day life, human body comes in contact with various toxins related to environment, indirectly. Ailments of liver are on the rise in the 21 st century. The spectrum of liver disorders is vast and it ranges from hepatitis to cirrhosis of diverse etiologic origins such as viral diseases, autoimmune disorders; drug induced liver injury and different types of carcinomas. Despite advances in modern medicine there is no definitive cure for liver disorders. So, there is an emergent need to develop potent agents, which not only prevent hepatic damage but also be curative. The drug isoniazid (INH) is one of the 1 st line drugs used for prophylaxis as well as treatment of tuberculosis. INH is associated with significant hepatotoxicity. Hepatotoxicity in patients on INH treatment is encountered in approximately 2% cases, which if not recognized timely can have fatal outcome. 19 INH was found out to be the leading cause of drug induced liver injury in the United States and hepatotoxicity resulting from the use of INH treatment is significantly underreported. 20 The presumed mechanism of INH hepatotoxicity is that INH gets converted to acetylisoniazid by the enzyme NAT2 which then gets eliminated by the kidney; acetylisoniazid further gets transformed into acetylhydrazine and then to potential hepatotoxic metabolite acetyl diazine by the CYP enzymes which is toxic by itself as it gets converted to reactive acetyl onium ion, acetyl radical and ketene, which binds covalently to hepatic macromolecules causing irreversible damage to the hepatocytes. 21 In the present study INH was given to rats orally in a dose of 50m/kg for 28 days to induce hepatotoxicity. In India herbal therapy for liver ailments based on the traditional systems of medicine has been used for a long time. Despite the commercial popularity of several herbal remedies for liver diseases in particular, they still remain unacceptable treatment modalities. In order to develop effective drugs for liver disease based on the knowledge of the traditional systems proper therapeutic evaluation of herbal products in animal models are imperative. It is of utmost importance to carefully combine the knowledge of the traditional systems of medicine with that of the modern concept of evidencebased medicinal evaluation, standardization and randomized placebo controlled clinical trials to support clinical efficacy of the new drug. 22 The seeds of Nigella sativa plant have a long history of being a diversely beneficial for numerous ailments. For thousands of years people all over the world have used the Black Seed to cure diseases and sustain health in general. Many studies have been conducted to demonstrate the hepatoprotective activity of N. sativa plant.
23,24 Also Trivedi et.al in 2013 demonstrated the hepatoprotective activity of thymoquinone, which is the active principle of Nigella sativa seed oil against the antitubercular drug induced hepatotoxicity in rats has been reported. 25 In the present study we explored the hepatoprotective potential of the N. sativa oil in isoniazid (INH) induced hepatic damage in rats. The results of the biochemical parameters depicts that after 15 days of treatment with N. sativa oil 0.5ml/kg and 1ml/kg in INH induced hepatotoxicity there was reduction in the AST, ALT and billirubin levels significantly in comparison to the negative control group. All the liver function parameters except ALP in the animals of the positive control group showed significant reduction, T. bilirubin (p<0.001), AST (p<0.001) and ALT (p<0.001) in comparison to the negative control group. ALP value in the positive control group also showed reduction but was not statistically significant when compared to the negative control group. In the rats of the N. sativa oil 0.5ml/kg group bilirubin level showed significant (p<0.001) reduction in comparison to the negative control group. Serum ALT level also exhibited significant (p<0.01) reduction, serum AST and ALP levels were reduced but were not statistically significant in comparison to the negative control group. The animals treated with N. sativa oil 1ml/kg exhibited significant reduction in the levels of total billirubin (p<0.001), AST (p<0.01) and ALT (p<0.001) when compared to the negative control group, the ALP level also showed reduction in comparison to the negative control group but it was not statistically significant. The percentage of hepatoprotection offered by N. sativa oil 0.5ml/kg dose was 65%, 29%, 58% and 29% for bilirubin AST, ALT and ALP respectively. The percentage of hepatoprotection in the 1ml/kg dose group was72%, 66%, 72% and 36% for bilirubin AST, ALT and ALP respectively The hepatoprotective activity of N. sativa oil shown in the biochemical parameters are supported by the findings of the histopathological examination in the therapeutic study. The histopathological parameters studied were degeneration, necrosis, fibrosis and regeneration. In N. sativa oil 0.5ml/kg dose group, there was a decrease in the degeneration, necrosis and fibrosis scores but were not statistically significant and also, there was significant regeneration (p<0.01) in comparison to the negative control group. In N. sativa oil 1ml/kg group the degeneration (p<0.01), necrosis scores (p<0.05) and fibrosis scores (p<0.05) exhibited significant reduction and also there was significant regeneration (p<0.001) in comparison to the negative control group. Both the doses of N. sativa oil showed therapeutic efficacy against INH induced liver injury by decreasing the elevation of AST, ALT, ALP and Total bilirubin. But the effect was more pronounced with N. sativa 1ml/kg dose. N. sativa oil 1ml/kg provided greater hepatoprotective effect. Comparative histopathological study of the liver from different groups of rats corroborated the hepatoprotective activity of N. sativa oil). Liver sections of the animals treated with N. sativa oil 0.5ml/kg and 1ml/kg dose exhibited significant liver protection against INH in this study, which is evident by the presence of regenerating and lesser degenerating hepatocytes, fibrotic bridges and necrotic foci in the prophylactic study. The protection offered by N. sativa oil 1ml/kg dose though somewhat lesser than the standard drug silymarin but was considerable when compared to the liver slices of the rats treated with isoniazid (INH) alone. Oxidative stress has been postulated as one of the major mechanisms by which the antitubercular drugs, namely isoniazid (INH) and rifampicin cause damage to the hepatocytes. After combined treatment of INH and rifampicin the glutathione and related thiols, which serve the purpose of preventing tissue from oxidative damage, get reduced significantly in blood and liver tissue. The result of which is microvesicular deposition of fats in the hepatocytes and inflammation of the portal triad. Thus isoniazid's (INH) hepatotoxicity appears to be mediated by oxidative stress. 26 The hepatoprotective activity of the N. sativa oil can be ascribed to its well documented pharmacological properties like anti-inflammatory property which might be capable of preventing inflammatory damage to the liver tissue. The probable mechanism by which N. sativa oil offers protection against antitubercular drug induced hepatotoxicity may be due to its immunomodulatory and antioxidant activity.
Thymoquinone, active constituent of N. sativa oil has been reported to possess antioxidant and antiperoxidative effects. 29 This active principle of N. sativa has been reported to effectively improve plasma and liver antioxidant activity. It also enhanced the liver antioxidant genes. 30 The effectiveness of Thymoquinone, the active constituent of N. sativa in ameliorating the hepatotoxicity in rats induced by the antitubercular drugs used in combination has also been demonstrated. 25 
CONCLUSION
The findings of our study demonstrate that N. sativa oil administration significantly improved the liver biochemical and histological parameters in a dose dependent fashion. The hepatoprotective action of N. sativa oil might be ascribed to the presence of antioxidant phytochemicals which might have countered the free radical damage to the hepatocytes caused by isoniazid (INH). These were the results of a preliminary study and further detailed investigations are required to pinpoint the mechanism of hepatoprotection offered by N. sativa oil.
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